14973 completed. 14973 Phase 2, 2792 Phase 1, 401 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14973 | Completed 14973 |
| Phase 1 | 2792 | Completed 2792 |
| Phase 3 | 401 | Completed 401 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy 0.02 mg/kg of DGPR1008 Injection was administered 24 hours before surgery, 0.04 mg/kg of DGPR1008 Injection was administered 24 hours before surgery, 0.06 mg/kg of DGPR1008 Injection was administered 24 hours before surgery - Prostate Cancer | Phase 2 | Completed | Zhu Yinjie | 18 | 2026-03-20 | 2026-09-30 |
| Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy Coenzyme Q 10, Paclitaxel - Breast Cancer | Phase 2 | Completed | Damanhour University | 50 | 2025-11-10 | 2026-04-08 |
| Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients Pentoxifylline 400mg plus chemotherapy - Doxorubicin Induced Cardiotoxicity, Breast Cancer | Phase 2 | Completed | Tanta University | 46 | 2025-09-01 | 2026-09-30 |
| A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients. Tislelizumab, Afatinib, Low dose radiotherapy - Head and Neck Squamous Cell Carcinoma, Low-dose Radiotherapy | Phase 2 | Completed | West China Hospital | 98 | 2025-06-28 | 2026-06-30 |
| ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care ConnectedNest, Standard of care - Cancer | Phase 2 | Completed | University of Minnesota | 400 | 2025-06-12 | 2026-09-10 |
| Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer Pembrolizumab, Carboplatin, Paclitaxel - Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Completed | MedSIR | 31 | 2025-05-29 | 2026-07-27 |
| A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma WTX-330 - Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | Werewolf Therapeutics, Inc. | 24 | 2025-04-21 | 2026-10-19 |
| Oral Mecobalamin for TKI-Associated Hand-Foot Syndrome in Advanced Thyroid Cancer Mecobalamin, Urea Ointment - Thyroid Cancer, Hand-foot Syndrome | Phase 2 | Completed | Li Zhihui | 100 | 2025-04-12 | 2026-11-03 |
| SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen - Rectal Adenocarcinoma, High-Risk Cancer | Phase 2 | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 49 | 2025-04-02 | 2026-08-04 |
| Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial L-arginine Oral Suspension, L-glutamine Oral Suspension, Maltodextrin Oral Suspension (Control) - Radiation Induced Oral Mucositis, Oral Mucositis | Phase 2 | Completed | Ain Shams University | 84 | 2025-04-01 | 2026-01-30 |
| Heavy Strength Training in Head and Neck Cancer Survivors Experimental - Head and Neck Neoplasms, Head and Neck Cancer | Phase 2 | Completed | University of Alberta | 37 | 2025-02-17 | 2026-08-12 |
| Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy oral iohexol, Lymphangiography and Embolization - Chylous Ascites, Abdominal Neoplasm | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 42 | 2025-02-15 | 2026-03-06 |
| COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients the COMBO Endoscopy Oropharyngeal Airway - Hypoxia, Esophageal Cancer | Phase 2 | Completed | Zhejiang University | 107 | 2025-02-04 | 2025-05-21 |
| Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation - Hypoxia, Esophageal Cancer | Phase 2 | Completed | Zhejiang University | 50 | 2025-02-04 | 2025-06-25 |
| Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM) [6,6-²H₂]-Glucose - Glioma, GBM | Phase 2 | Completed | Stanford University | 2 | 2025-01-30 | 2026-09-30 |
| Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya Artesunate vaginal inserts, Placebo vaginal inserts - Human Immunodeficiency Virus, Human Papillomavirus | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 120 | 2025-01-22 | 2026-05-14 |
| Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3) Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer | Phase 2 | Completed | University of Southern California | 120 | 2025-01-16 | 2026-05-06 |
| Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio), Lidocaine, Biopsy of Prostate - Prostate Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 350 | 2025-01-09 | 2026-02-17 |
| A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer Letrozole, Letrozole and atorvastatin, Fulvestrant - Breast Cancer | Phase 2 | Completed | Lund University Hospital | 126 | 2025-01-02 | 2025-09-10 |
| Semaglutide in Women With Polycystic Ovary Syndrome and Obesity Metformin with Semaglutide - Polycystic Ovary Syndrome (PCOS) Women, Obesity | Phase 2 / Phase 3 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 31 | 2025-01-01 | 2026-10-07 |
Showing 20 of 14973. Sign in to see all of them.
Breast Neoplasms (1608) · Carcinoma, Non-Small-Cell Lung (1193) · Prostatic Neoplasms (946) · Multiple Myeloma (747) · Colorectal Neoplasms (735) · Leukemia, Myeloid, Acute (697) · Lymphoma (696) · Lung Neoplasms (657) · Leukemia (651) · Neoplasm Metastasis (613) · Melanoma (604) · Lymphoma, Non-Hodgkin (558) · Ovarian Neoplasms (541) · Pancreatic Neoplasms (526)
Neoplasms by Site (9959) · Neoplasms by Histologic Type (7709) · Hemic and Lymphatic Diseases (3663) · Neoplasms, Glandular and Epithelial (3046) · Immune System Diseases (2833) · Immunoproliferative Disorders (2706) · Lymphoproliferative Disorders (2686) · Digestive System Diseases (2660) · Urogenital Diseases (2635) · Digestive System Neoplasms (2599) · Hematologic Diseases (2519) · Urogenital Neoplasms (2465) · Skin and Connective Tissue Diseases (2402) · Skin Diseases (2380)
Cyclophosphamide (881) · Cisplatin (793) · Gemcitabine (743) · Carboplatin (707) · Paclitaxel (705) · Bevacizumab (672) · Radiotherapy (667) · Docetaxel (628) · Fluorouracil (463) · Rituximab (461) · Oxaliplatin (438) · Doxorubicin (423) · Dexamethasone (397) · Capecitabine (396) · Etoposide (395)
National Cancer Institute (NCI) (1019) · M.D. Anderson Cancer Center (484) · Memorial Sloan Kettering Cancer Center (397) · Eli Lilly and Company (235) · Dana-Farber Cancer Institute (198) · Alliance for Clinical Trials in Oncology (192) · Novartis Pharmaceuticals (192) · Hoffmann-La Roche (172) · Fred Hutchinson Cancer Center (136) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (135) · Pfizer (133) · Mayo Clinic (130) · Bristol-Myers Squibb (120) · SCRI Development Innovations, LLC (118) · SWOG Cancer Research Network (112)
United States (9060) · France (1435) · Canada (1289) · Germany (1180) · Italy (1100) · Spain (1089) · United Kingdom (1013) · China (929) · South Korea (721) · Belgium (664) · Australia (583) · Netherlands (547) · Poland (422) · Japan (358) · Switzerland (328)
PMID 37185961, PMID 31401903, PMID 32499241, PMID 34515338, PMID 37146227, PMID 25057165, PMID 38979716, PMID 25667295, PMID 22473314, PMID 23524640, PMID 27238653, PMID 28410911, PMID 31395089, PMID 33337539, PMID 34037241, PMID 35101941, PMID 35622074, PMID 23065508, PMID 25577718, PMID 27209293, PMID 35170751, PMID 37407274, PMID 19238149, PMID 22555974, PMID 22586319, PMID 23442309, PMID 23633099, PMID 26291023, PMID 29358183, PMID 30062662, PMID 33241650, PMID 35549810, PMID 35833116, PMID 36184192, PMID 36648215, PMID 36852452, PMID 37934000, PMID 38502198, PMID 40135712, PMID 41044356, PMID 17242396, PMID 18596230, PMID 19097774, PMID 19192962, PMID 23054212, PMID 23620574, PMID 23834234, PMID 23922302, PMID 24722180, PMID 24983357
U10CA032102 (127), U10CA031946 (113), 2014 (112), 2016 (111), 2009 (110), 2017 (106), 2008 (100), P30CA015083 (92), 2015 (88), P30CA015704 (83), 2018 (80), 2019 (64), P30CA016672 (64), P30CA006973 (61), P30CA043703 (61)